Get the Stockscreener App
0.5014
3.77%
-0.0286
BiomX Inc stock is traded at $0.5014, with a volume of 132.40K.
It is down -3.77% in the last 24 hours and down -8.11% over the past month.
BiomX Inc., a clinical stage company, develops bacteriophage-based therapies for the treatment and prevention of diseases from the microbiome. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), liver, primary sclerosing cholangitis, and cancer. The company's lead product candidate BX001, which is in phase I that helps to modify the appearance of skin in various skin types, including oily and acne-prone skin type; BX002, a therapeutic phage product to treat IBD; BX003, targets bacteria associated with progressive liver disorder (PSC), a rare inflammatory liver disease; and CRC, targets strains of bacteria found in colorectal cancer tumors. The company has license agreement collaboration with The Weizmann Institute of Science to develop, test, manufacture, produce, and sell microbiome-based therapeutic product candidate; Takeda, develops formulations for phage therapy manufacturing intermediates and for the final form to be administered; Keio University and JSR Corporation, a set of bacterial targets for the development and commercialization of phage therapies to treat IBD; and Janssen Research & Development, LLC to utilize XMarker microbiome-based biomarker discovery platform. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.
See More
Previous Close:
$0.53
Open:
$0.522
24h Volume:
132.40K
Relative Volume:
0.03
Market Cap:
$13.41M
Revenue:
-
Net Income/Loss:
$-26.56M
P/E Ratio:
-0.7713
EPS:
-0.65
Net Cash Flow:
$-22.29M
1W Performance:
+0.24%
1M Performance:
-8.11%
6M Performance:
-12.79%
1Y Performance:
-52.34%
1-Day Range:
$0.5003
$0.53
1-Week Range:
$0.5003
$0.5495
52-Week Range:
$0.34
$1.1609
BiomX Inc Stock (PHGE) Company Profile
Name
BiomX Inc
Sector
Industry
Phone
972 7 23942377
Address
7 Pinhas Sapir Street, 2nd Floor, Ness Ziona
Compare PHGE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PHGE
BiomX Inc
|
0.5052 | 14.07M | 0 | -26.56M | -22.29M | -0.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
378.90 | 96.56B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.00 | 60.08B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.08 | 61.15B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
708.51 | 44.66B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
327.81 | 36.23B | 3.81B | -644.79M | -669.77M | -6.24 |
BiomX Inc Stock (PHGE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-21 | Initiated | Ladenburg Thalmann | Buy |
BiomX Inc Stock (PHGE) Latest News
Sector ETF performance correlation with BiomX Inc.2025 Technical Patterns & Reliable Price Action Trade Plans - newser.com
BiomX Inc. recovery potential after sell offPortfolio Risk Report & Free Long-Term Investment Growth Plans - newser.com
BiomX Inc. stock trend outlook and recovery pathWeekly Earnings Recap & Expert Approved Trade Ideas - newser.com
Death Cross: Why is BiomX Inc stock going up2025 Stock Rankings & Real-Time Market Sentiment Reports - خودرو بانک
Is this a good reentry point in BiomX Inc.Trend Reversal & Low Risk Entry Point Guides - newser.com
Applying Wyckoff theory to BiomX Inc. stock2025 Earnings Surprises & Verified Entry Point Signals - newser.com
Relative strength of BiomX Inc. in sector analysisJuly 2025 Update & Verified Momentum Stock Watchlist - newser.com
Aug Movers: What are the analyst revisions for BiomX IncIs OBDC stock a good investment in YEARMarket Activity Recap & Daily Profit Focused Stock Screening - خودرو بانک
Breakout Move: How liquid is TDSPRV stockJuly 2025 Macro Moves & Verified Trade Idea Suggestions - khodrobank.com
Combining machine learning predictions for BiomX Inc.July 2025 Trends & Safe Entry Zone Tips - newser.com
Visual trend scoring systems applied to BiomX Inc.July 2025 Analyst Calls & Daily Technical Stock Forecast Reports - newser.com
Profit Review: Is BiomX Inc gaining market shareMarket Activity Report & AI Enhanced Trading Alerts - خودرو بانک
Support Test: What is BiomX Incs 5 year growth outlook2025 Big Picture & Low Drawdown Investment Ideas - khodrobank.com
Pattern recognition hints at BiomX Inc. upsideWeekly Trend Report & Risk Controlled Daily Trade Plans - newser.com
How high can BiomX Inc. stock goWeekly Gains Report & Detailed Earnings Play Strategies - newser.com
Multi factor analysis applied to BiomX Inc.Earnings Trend Report & Weekly High Conviction Ideas - newser.com
BiomX Inc. stock daily chart insights2025 Pullback Review & Pattern Based Trade Signal System - newser.com
Aug Wrap: Is BiomX Inc a cyclical or defensive stockEarnings Miss & Smart Swing Trading Techniques - خودرو بانک
Retail Trends: Can BiomX Inc stock outperform in a bear marketTreasury Yields & Free Weekly Watchlist of Top Performers - خودرو بانک
Short Covering: Is GGTRT still a buy after recent gainsEarnings Recap Report & Fast Entry Momentum Trade Alerts - خودرو بانک
Market Wrap: Does BiomX Inc stock have upside surprise potentialTake Profit & Stepwise Trade Signal Implementation - خودرو بانک
Using data tools to time your BiomX Inc. exitQuarterly Profit Report & Weekly Watchlist for Consistent Profits - newser.com
Published on: 2025-09-14 21:58:35 - newser.com
BiomX announces U.S. FDA placed clinical hold on Phase 2b trial of BX004 - MSN
What candlestick patterns are forming on BiomX Inc.Weekly Trade Analysis & Growth Oriented Trading Recommendations - newser.com
BiomX Inc. Added to High Probability Setup ListWeekly Trend Recap & Weekly High Potential Alerts - newser.com
BiomX Inc Stock (PHGE) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):